Literature DB >> 30556872

Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.

L-L Zhang1, D Hu, L-H Zou.   

Abstract

OBJECTIVE: The aim of this study was to explore whether maternally expressed gene 3 (MEG3) could facilitate the proliferation and migration of oral squamous cell carcinoma (OSCC) cells by selectively binding to miR-21, thereby participating in the progression of OSCC. PATIENTS AND METHODS: The expression levels of MEG3 and miR-21 in OSCC tissues and normal control tissues were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The effects of MEG3 and miR-21 on cell proliferation and migration were examined by cell counting kit-8 (CCK-8), transwell, and scratch assay, respectively. Meanwhile, cell cycle was detected using flow cytometry. The binding relationship between miR-21 and MEG3 was confirmed by dual luciferase assay. In addition, MEG3 and miR-21 were simultaneously knock-down to figure out whether MEG3 could regulate the proliferation and migration of OSCC cells through targeted binding to miR-21.
RESULTS: QRT-PCR results indicated that MEG3 expression in OSCC tissues was remarkably lower than that of normal control tissues. However, the expression of miR-21 was significantly higher in OSCC tissues. Meanwhile, it was found that inhibiting MEG3 expression in OSCC cell lines could significantly promote cell proliferation and migration, while the simultaneous inhibition of miR-21 showed the opposite effect. Dual Luciferase assay results revealed that MEG3 could selectively bind to miR-21. In addition, we demonstrated that the knockdown of MEG3 in Tca-8113 and CAL-27 cells partially reversed the inhibitory effect of downregulated-miR-21 on cell proliferation and migration. These results further suggested that MEG3 might regulate OSCC cell proliferation via selectively binding to miR-21.
CONCLUSIONS: Low expression of MEG3 can promote the proliferation and migration of OSCC cells through targeted binding to miR-21.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30556872     DOI: 10.26355/eurrev_201812_16529

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

Authors:  Jian-Xian Lin; Xin-Sheng Xie; Xiong-Feng Weng; Sheng-Liang Qiu; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ping Li; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Oncol Rep       Date:  2019-03-05       Impact factor: 3.906

2.  Effects of LncRNA MEG3 on immunity and autophagy of non-small cell lung carcinoma through IDO signaling pathway.

Authors:  Chuanqiang Wang; Xiangbo Tao; Jungong Wei
Journal:  World J Surg Oncol       Date:  2021-08-16       Impact factor: 2.754

Review 3.  The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma.

Authors:  Man Jiang; Fang Liu; An-Gang Yang; Wei Wang; Rui Zhang
Journal:  Mol Ther Oncolytics       Date:  2021-12-06       Impact factor: 7.200

Review 4.  Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer.

Authors:  Karen Yamaguchi; Tomofumi Yamamoto; Junichiro Chikuda; Tatsuo Shirota; Yusuke Yamamoto
Journal:  Biomolecules       Date:  2022-02-09

Review 5.  Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises.

Authors:  Cing-Syuan Lei; Hsing-Jien Kung; Jing-Wen Shih
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

6.  LncRNA MALAT1 Accelerates Cervical Carcinoma Proliferation by Suppressing miR-124 Expression in Cervical Tumor Cells.

Authors:  Tian Liang; Yuchen Wang; Yu Jiao; Shanshan Cong; Xinyan Jiang; Lina Dong; Guangmei Zhang; Dan Xiao
Journal:  J Oncol       Date:  2021-06-15       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.